Username or e-mail:
*
Password:
*
Forgot Password?
British Columbia Drug and Poison Information Centre (BC DPIC)
Healthcare Professionals
Health Headlines
Weblinks
About DPIC
Contact
Terms & Conditions
Index
Search this site:
Poison Information
24-Hour Line:
1-800-567-8911 or
604-682-5050
General Information
Prevention Tips
Prevention Material
Fact Sheets
BC Poison Control
Springtime Hazards
Holiday Hazards
Poison FAQ
Drug Information
BC Healthcare Professionals
Drug Information Line
1-866-298-5909 or
604-707-2787
(Mon - Fri, 9am to 4pm)
Clinical Practice Guidelines
Drug Product Listings
Safe Medication Use
Publications
DI Perpectives Newsletter
Drug Desk Newsletter
Drug Information Reference
Home
›
Drug Product Listings
› Liraglutide
Liraglutide
Trade Name:
Victoza
Manufacturer/Distributor:
Novo Nordisk
Classification:
Incretin mimetic agent
Human glucagon like peptide-1
ATC Class:
A10BX07 Liraglutide
Status:
active
Notice of Compliance (yyyy/mm/dd):
2010/05/21
Date Marketed in Canada (yyyy/mm/dd):
2010/05/27
Presentation:
Injection: 6 mg/mL; DIN: 02351064
Comments:
For once-daily use in adults with type-2 diabetes when used in combination with metformin or metformin plus a sulfonylurea.
Source:
Product monograph
Posted
Updated
2010-07-06 16:21
2010-07-06 16:27
Back to:
Drug Product Listings
Browse by keywords:
diabetes mellitus: type 2
liraglutide
-
A
+
A
Follow DPIC
Facebook
Twitter